Mark Avigan - Concepedia

Author

Mark Avigan

Also Known As

Avigan, Mark, Avigan, Mark I., Hartung, Thomas, M Avigan, M I Avigan, M. AVIGAN, M. Avigan, M. I. Avigan, M.I. Avigan, Mark Avigan

104

Publications

5.3K

Citations

H-Index

119

Concepts

All Affiliations

Center for Drug Evaluation and Research United States Food and Drug Administration National Institutes of Health Georgetown University National Institute of Diabetes and Digestive and Kidney Diseases

About

Mark Avigan is an author at Center for Drug Evaluation and Research specializing in medicine, hepatology, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	25	2K
2	Health Sciences	5	5	234
3	Natural Sciences	4	4	541
4	Public Health	1	1	16
5	Social Sciences	1	1	18

Mark Avigan

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Hepatosplenic T Cell Lymphoma Associated With Infliximab Use in Young Patients Treated for Inflammatory Bowel Disease Ann Corken Mackey, Lanh Green, Li‐ching Liang, Journal of Pediatric Gastroenterology and Nutrition Peripheral T CellImmunodeficienciesRare CancersImmunologyGastroenterology	2007	510
A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. Robert Duncan, Leonard S. Bazar, Gregory Michelotti, Genes & Development Molecular RegulationMolecular BiologyMolecular GeneticsTranscriptional RegulationProtein Expression	1994	321
Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro. Masato Takimoto, Takeshi Tomonaga, Michael J. Matunis, Journal of Biological Chemistry	1993	223
Randomized trial of chlorambucil for primary biliary cirrhosis Jay H. Hoofnagle, Gary L. Davis, Daniel F. Schafer, Gastroenterology HepatologyBiliary TractLiver PhysiologyGastroenterologyPathology	1986	157
A far upstream element stimulates c-myc expression in undifferentiated leukemia cells. Mark Avigan, Benjamin J. Strober, David Levens Journal of Biological Chemistry C-myc ExpressionMolecular BiologyTumor BiologyMyeloid NeoplasiaHematological Malignancy	1990	136
Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients Namita Kothary, Ida-Lina Diak, Allen Brinker, Journal of the American Academy of Dermatology InflammationAutoimmune DiseaseMedicinePathologyClinical Dermatology	2011	133
Telithromycin‐associated hepatotoxicity Allen Brinker, Ronald T. Wassel, Jenna Lyndly, Hepatology	2008	115
Using controlled clinical trials to learn more about acute drug-induced liver injury Paul B. Watkins, Paul J. Seligman, John Pears, Hepatology Hepatic DisordersHepatologyLiver InjuryLiver PhysiologyPharmacology	2008	113
Delivery of c-myc Antisense Phosphorothioate Oligodeoxynucleotides to Hematopoietic Cells in Culture by Liposome Fusion: Specific Reduction in c-myc Protein Expression Correlates with Inhibition of Cell Growth and DNA Synthesis S.L. Loke, C.A. Stein, X. Zhang, Current topics in microbiology and immunology Cell TherapyImmunologyDna SynthesisOligonucleotideC-myc Protein Expression	1988	103
Brief Communication: Characteristics of Spontaneous Cases of Tuberculosis Associated with Infliximab Angela Raval, Gita Akhavan-Toyserkani, Allen Brinker, Annals of Internal Medicine	2007	83

Page 1